As part of an ambitious plan to transform the culture at Vidant Health and improve the experience of patients and team members alike, Oehlert helped reframe the organization’s goals to consider kindness and compassion as part of strategic excellence.
Forty years after the declaration of war on cancer, one of the most profound shifts in cancer care today is a new focus on treating those living beyond cancer, as well as those living with cancer.
Amita Patel, NPC, Regional Cancer Care Associates, Central Jersey Division, talks about benefits of a multidisciplinary care team and some issues that providers should be aware of when treating patients undergoing chemotherapy.
Jackie Miller, BSN, RN, OCN, works to provide emotional support for children whose parents have cancer.
Patients with cancer are faced with chronic pain that nurses often cannot manage properly due to outdated restrictions and practices.
Nurses play an important role in the administration of biosimilars and the education of patients receiving them.
In postmenopausal diabetic women, metformin use was associated with lower ER and PR breast cancer incidence.
Paula Raska, a research associate from the Cleveland Clinic, discusses a study of patient navigation.
During and after treatment, the majority of patients will be back at their jobs sometime after diagnosis and treatment, but that doesn’t have to come with emotional distress if possible outcomes are discussed.
Expert Jeffrey Lancet, MD, discusses the emerging agents in treating acute myeloid leukemia (AML) and challenges that still exist for improving patient outcome.
Mary Lou Woodford, from the Cancer Resource Foundation, provides guidance on staying compliant with the new patient navigation accreditation standards from the American College of Surgeons Commission on Cancer.
Nausea and upper GI discomfort are frequently linked with use of the oral SERD.
Kathryn H. Schmitz, PhD, MPH, professor of Public Health Sciences and associate director of Population Sciences at the Penn State Cancer Institute, discusses benefits that can be reaped from running parallel mouse and human studies.
The month of May is Lung Cancer Hope Month, and here are just 5 reasons we can all be hopeful.
Being a caregiver in the ER is usually pretty awful. It feels like I'm always in the way.
Beth Sandy, MSN, CRNP, discusses the application of 2 FDA approved drugs for patients with non–small cell lung cancer and an exon 20 insertion mutation.
A combination of cabozantinib and atezolizumab improved the PFS in patients with Advanced HCC
Laura J. van’t Veer, PhD, discussed determining more accurate methods of treatment for patients with early- and late-state breast cancer based on advances in genetic testing, specifically the 70-gene prognostic signature.
Rebecca Sutphen, MD, from the University of South Florida, discusses the importance of connecting patients with clinical trials.
There are socioeconomic and ethnic disparities in young adults who receive a diagnosis of colorectal and gastric cancers, according to Amir Khan, MD, from City of Hope.
Shared practical advice on the management of toxicities associated with antibody drug conjugate therapy in both the breast cancer and GI cancer settings.
Combining PARP inhibitors with another kind of agent may be key in overcoming resistance.
Alix Beaupierre, RN, BSN, OCN, Moffitt Cancer Center, explains the patient education program created for a recent CAR T-cell therapy clinical trial.
Jessica Ryan, MD, breast surgeon, Elliot Breast Health Center, Manchester, New Hampshire, discusses the role of oncology nurses in extreme oncoplasty.
Patrick Spencer, RN, OCN provides important points to cover when counseling a patient with multiple myeloma receiving treatment with daratumumab.
Mark Lazenby, PhD, APRN, FAPOS, associate professor at Yale School of Nursing and incoming president of American Psychosocial Oncology Society (APOS), discusses psychosocial topics that concern APOS.
Yale-New Haven Hospital (YNHH) currently credentials more than 400 advanced practice nurses (APNs) who practice in a wide range of roles and geographic locations. The number of practitioners more than doubled in the past 3 years, and now more than 50 APNs are practicing in oncology in Smilow Cancer Hospital at YNHH and at community care centers.
Christian Capitini discusses the responses to immunotherapy.